April 22 - Breakingviews columnists discuss the pharma M&A machine’s bid for its rival and activist investor Bill Ackman’s unusual role in backing the proposed deal.
01:13
01:55
00:47
01:34
00:52
01:42
00:56
01:13
01:11
00:20
02:38
01:53
01:54
00:48
00:24
01:43
00:25
01:24
01:23
01:49
01:13
00:56
01:13
00:20
01:19
01:15
01:03
01:07
01:09
01:13
02:03
01:48
01:04
01:00
01:11
01:24
01:33
01:31
01:34
01:06
00:52
00:48
01:43
00:25
01:23
01:24
00:22
01:15
01:02
00:47
00:34
01:23
01:03
01:14
00:46
01:05
01:16
01:00
01:02
01:13
01:53
01:12
01:19
01:21
01:22
02:02
05:59
01:30
01:00
01:20
01:42
01:14
01:54
01:54
01:18
04:56
01:36
01:14
01:09
01:48
02:08
00:47
01:22
01:13
01:18
01:10
01:59
01:13
01:14
01:10
00:52
01:29
01:12
01:02
01:25
01:13
01:58
01:05
01:31
01:45
00:47
01:26
01:13
01:22
01:22
01:15
01:20
01:33
01:28
01:48
02:33
01:28
03:40
01:05
01:15
01:28
01:24
02:10
01:14
02:04